Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.38 is 18% below its 5-year average of 1.68, near the low end of its 5-year range (1.10–3.23).
As of the fiscal period ended Tuesday, June 30, 2026. 9.14% below its 12-month average of 1.51.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.38.
QUICK RATIO (ACID-TEST)
1.38
QUICK RATIO (ACID-TEST) AVG TTM
1.51
QUICK RATIO (ACID-TEST) AVG 3Y
1.36
QUICK RATIO (ACID-TEST) AVG 5Y
1.68
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-9.14%
CURRENT VS 3Y AVG
+1.35%
CURRENT VS 5Y AVG
-18.20%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 613 covered companies
CURRENT VS SECTOR MEDIAN
-53.99%
vs the sector median at left
LifeStance Health Group, Inc.
Market Cap
$4.64B
Quick Ratio (Acid-Test)
1.38
TTM Avg
1.51
3Y Avg
1.36
5Y Avg
1.68
Market Cap
$4.61B
Quick Ratio (Acid-Test)
6.95
TTM Avg
6.77
3Y Avg
6.23
5Y Avg
10.87
Market Cap
$4.71B
Quick Ratio (Acid-Test)
11.31
TTM Avg
9.52
3Y Avg
6.89
5Y Avg
6.89
Market Cap
$4.73B
Quick Ratio (Acid-Test)
26.10
TTM Avg
14.27
3Y Avg
14.23
5Y Avg
14.47
Market Cap
$4.82B
Quick Ratio (Acid-Test)
2.74
TTM Avg
2.74
3Y Avg
3.13
5Y Avg
4.87
Market Cap
$4.41B
Quick Ratio (Acid-Test)
4.68
TTM Avg
3.02
3Y Avg
3.88
5Y Avg
4.28
Market Cap
$4.38B
Quick Ratio (Acid-Test)
0.66
TTM Avg
0.63
3Y Avg
0.81
5Y Avg
1.13
Market Cap
$4.35B
Quick Ratio (Acid-Test)
5.08
TTM Avg
3.83
3Y Avg
4.06
5Y Avg
4.06
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LifeStance Health Group, Inc. (LFST) | $4.64B | 1.38 | 1.51 | 1.36 | 1.68 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.61B | 6.95 | 6.77 | 6.23 | 10.87 |
| BillionToOne, Inc. (BLLN)vs › | $4.71B | 11.31 | 9.52 | 6.89 | 6.89 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.73B | 26.10 | 14.27 | 14.23 | 14.47 |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.82B | 2.74 | 2.74 | 3.13 | 4.87 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.41B | 4.68 | 3.02 | 3.88 | 4.28 |
| Erasca, Inc. (ERAS)vs › | $4.89B | 8.29 | 9.94 | 10.32 | 11.01 |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.38B | 0.66 | 0.63 | 0.81 | 1.13 |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.35B | 5.08 | 3.83 | 4.06 | 4.06 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.04B | 7.02 | 8.28 | 8.59 | 7.77 |
Quick Ratio
1.38
Excludes inventory
Current Ratio
1.38
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.38 |
| 2026-03-31 | 1.48 |
| 2025-12-31 | 1.65 |
| 2025-09-30 | 1.58 |
| 2025-06-30 | 1.48 |
| 2025-03-31 | 1.47 |
| 2024-12-31 | 1.37 |
| 2024-09-30 | 1.32 |
| 2024-06-30 | 1.22 |
| 2024-03-31 | 1.18 |
| 2023-12-31 | 1.11 |
| 2023-09-30 | 1.10 |
| 2023-06-30 | 1.32 |
| 2023-03-31 | 1.17 |
| 2022-12-31 | 1.33 |
| 2022-09-30 | 2.25 |
| 2022-06-30 | 2.19 |
| 2022-03-31 | 2.10 |
| 2021-12-31 | 2.28 |
| 2021-09-30 | 3.12 |
| 2021-06-30 | 3.23 |
| 2021-03-31 | 1.13 |
| 2020-12-31 | 1.00 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
